Trump executive order lifts psychedelics biotechs

BioPharma Dive

Meant to speed research and access to psychedelics for mental health conditions, the order is the latest in a series of developments that, to Wall Street, make psychedelics a more investable space.

Policy / PricingNeuroscienceRead full story